The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...
Roche has agreed to acquire PathAI, a Boston-based digital pathology firm, for up to $1.05 billion. Roche plans to pay $750 ...
Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today’s artificial intelligence (AI) techniques now go far beyond mere automation: they make it possible ...
March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial ...
Like all forms of cancer, lung cancer is defined by uncontrolled cell division caused by loss of physiological tissue homeostasis and failure of apoptotic cell death mechanisms. Aberrant cell ...
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...
Hosted on MSN
AI pathology system SPARK offers new cancer insights
Researchers at University Hospital Cologne have developed SPARK, an AI-based pathology framework that autonomously generates and refines biological hypotheses from tissue images. Tested on over 5,400 ...
Roche (RHHBY) stock rises 1.55% following announcement of PathAI acquisition for $750M, enhancing AI-powered cancer ...
Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results